|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 69/67 | |
| C07C 59/01 | |||
| A61K 31/19 | |||
| A61K 31/22 | |||
| A61K 31/225 | |||
| C07B 59/00 |
| (11) | Number of the document | 2675771 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12704646.4 |
| Date of filing the European patent application | 2012-02-14 | |
| (97) | Date of publication of the European application | 2013-12-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/024974 |
| Date | 2012-02-14 |
| (87) | Number | WO 2012/112492 |
| Date | 2012-08-23 |
| (30) | Number | Date | Country code |
| 201161442451 P | 2011-02-14 | US | |
| 201161484296 P | 2011-05-10 | US |
| (72) |
TUNG, Roger, D., US
MORGAN, Adam, US
SILVERMAN, I., Robert, US
|
| (73) |
Concert Pharmaceuticals Inc.,
65 Hayden Avenue, Suite 3000N, Lexington, MA 02421,
US
|
| (54) | 4-HYDROXYBUTYRIC ACID DEUTERATED ANALOGS |
| 4-HYDROXYBUTYRIC ACID DEUTERATED ANALOGS |